Trevena Raises $35 Million
Trevena Inc., a Berwyn, Penn.-based developer of drugs that target G-protein coupled receptors, has raised $35 million in Series B funding from existing investors.Polaris Venture Partners and New Enterprise Associates co-led the round, and were joined by Alta Partners, Healthcare Ventures and Yasuda Enterprise Development Company. Trevena previously raised $24 million.
14 July 2010•5 mins read
